323 related articles for article (PubMed ID: 3074841)
1. Structure-activity relationship of reversible cholinesterase inhibitors: activation, channel blockade and stereospecificity of the nicotinic acetylcholine receptor-ion channel complex.
Albuquerque EX; Aracava Y; Cintra WM; Brossi A; Schönenberger B; Deshpande SS
Braz J Med Biol Res; 1988; 21(6):1173-96. PubMed ID: 3074841
[TBL] [Abstract][Full Text] [Related]
2. Multiple actions of anticholinesterase agents on chemosensitive synapses: molecular basis for prophylaxis and treatment of organophosphate poisoning.
Albuquerque EX; Deshpande SS; Kawabuchi M; Aracava Y; Idriss M; Rickett DL; Boyne AF
Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S182-203. PubMed ID: 2868960
[TBL] [Abstract][Full Text] [Related]
3. The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex.
Shaw KP; Aracava Y; Akaike A; Daly JW; Rickett DL; Albuquerque EX
Mol Pharmacol; 1985 Dec; 28(6):527-38. PubMed ID: 2417099
[TBL] [Abstract][Full Text] [Related]
4. Noncompetitive blockade of the nicotinic acetylcholine receptor-ion channel complex by an irreversible cholinesterase inhibitor.
Rao KS; Aracava Y; Rickett DL; Albuquerque EX
J Pharmacol Exp Ther; 1987 Jan; 240(1):337-44. PubMed ID: 2433427
[TBL] [Abstract][Full Text] [Related]
5. The inhibition and protection of cholinesterase by physostigmine and pyridostigmine against Soman poisoning in vivo.
Xia DY; Wang LX; Pei SQ
Fundam Appl Toxicol; 1981; 1(2):217-21. PubMed ID: 7184786
[TBL] [Abstract][Full Text] [Related]
6. Interactions of edrophonium, physostigmine and methanesulfonyl fluoride with the snake end-plate acetylcholine receptor-channel complex.
Fiekers JF
J Pharmacol Exp Ther; 1985 Sep; 234(3):539-49. PubMed ID: 2411911
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic analysis of contractile potentiation by cholinesterase inhibitors in rats.
Yamamoto K; Sawada Y; Iga T
J Pharmacokinet Biopharm; 1996 Aug; 24(4):327-48. PubMed ID: 9044164
[TBL] [Abstract][Full Text] [Related]
8. Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies.
Ikeda SR; Aronstam RS; Daly JW; Aracava Y; Albuquerque EX
Mol Pharmacol; 1984 Sep; 26(2):293-303. PubMed ID: 6090884
[TBL] [Abstract][Full Text] [Related]
9. The interaction of anticholinesterase agents with the acetylcholine receptor-ionic channel complex.
Albuquerque EX; Akaike A; Shaw KP; Rickett DL
Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S27-33. PubMed ID: 6327444
[TBL] [Abstract][Full Text] [Related]
10. Biochemical interactions of carbamates and ecothiophate with the activated conformation of nicotinic acetylcholine receptor.
Mansour NA; Valdes JJ; Shamoo AE; Annau Z
J Biochem Toxicol; 1987; 2():25-42. PubMed ID: 3508476
[TBL] [Abstract][Full Text] [Related]
11. Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells.
Storch A; Schrattenholz A; Cooper JC; Abdel Ghani EM; Gutbrod O; Weber KH; Reinhardt S; Lobron C; Hermsen B; Soskiç V
Eur J Pharmacol; 1995 Aug; 290(3):207-19. PubMed ID: 7589215
[TBL] [Abstract][Full Text] [Related]
12. The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist.
Varanda WA; Aracava Y; Sherby SM; VanMeter WG; Eldefrawi ME; Albuquerque EX
Mol Pharmacol; 1985 Aug; 28(2):128-37. PubMed ID: 2410768
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological estimation of the actions of acetylcholinesterase inhibitors on acetylcholine receptor and cholinesterase in physically isolated Aplysia neurones.
Oyama Y; Hori N; Evans ML; Allen CN; Carpenter DO
Br J Pharmacol; 1989 Mar; 96(3):573-82. PubMed ID: 2720293
[TBL] [Abstract][Full Text] [Related]
14. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties.
Pascuzzo GJ; Akaike A; Maleque MA; Shaw KP; Aronstam RS; Rickett DL; Albuquerque EX
Mol Pharmacol; 1984 Jan; 25(1):92-101. PubMed ID: 6323955
[TBL] [Abstract][Full Text] [Related]
15. Contractile and phosphatidylinositol responses of rat trachea to anticholinesterase drugs.
Shibata O; Tsuda A; Makita T; Iwanaga S; Hara T; Shibata S; Sumikawa K
Can J Anaesth; 1998 Dec; 45(12):1190-5. PubMed ID: 10051938
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning.
Deshpande SS; Viana GB; Kauffman FC; Rickett DL; Albuquerque EX
Fundam Appl Toxicol; 1986 Apr; 6(3):566-77. PubMed ID: 3699340
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the actions of carbamate anticholinesterases on the nicotinic acetylcholine receptor.
Sherby SM; Eldefrawi AT; Albuquerque EX; Eldefrawi ME
Mol Pharmacol; 1985 Mar; 27(3):343-8. PubMed ID: 3974572
[TBL] [Abstract][Full Text] [Related]
18. Competitive potentiation of acetylcholine effects on neuronal nicotinic receptors by acetylcholinesterase-inhibiting drugs.
Zwart R; van Kleef RG; Gotti C; Smulders CJ; Vijverberg HP
J Neurochem; 2000 Dec; 75(6):2492-500. PubMed ID: 11080202
[TBL] [Abstract][Full Text] [Related]
19. Clinical concentrations of edrophonium enhance desensitization of the nicotinic acetylcholine receptor.
Yost CS; Maestrone E
Anesth Analg; 1994 Mar; 78(3):520-6. PubMed ID: 8109771
[TBL] [Abstract][Full Text] [Related]
20. The use of carbamates, atropine, and 2-pyridine aldoxime methoiodide in the protection of Artemia salina against poisoning by carbophenothion.
Sánchez-Fortún S; Barahona V
Environ Toxicol Chem; 2001 Sep; 20(9):2008-13. PubMed ID: 11521828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
